SynthesisCardiovascular diabetology2021

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs.

Dario Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.